SCHEDULE: Vanguard Boosts Henry Schein Stake to 10.22%

The Vanguard Group reported an increased beneficial ownership of 10.22% in Henry Schein Inc., holding over 12 million shares of common stock.

Summary

• The Vanguard Group has filed an Amendment No. 13 to Schedule 13G, disclosing its beneficial ownership in Henry Schein Inc.
• As of November 28, 2025, The Vanguard Group beneficially owns 12,036,336 shares of Henry Schein Inc. common stock.
• This ownership represents 10.22% of the class of securities.
• The Vanguard Group holds sole voting power over 0 shares and shared voting power over 582,796 shares.
• The group holds sole dispositive power over 11,146,598 shares and shared dispositive power over 889,738 shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Henry Schein Inc.

Sentiment

Score: 7

Explanation: The filing indicates a significant, passive institutional ownership stake by The Vanguard Group, which is generally a neutral to slightly positive signal of market confidence, without implying any active management or change in company fundamentals.

Positives

• The disclosure of a significant 10.22% stake by a major institutional investor like The Vanguard Group can signal continued institutional confidence in Henry Schein Inc.

Risks

• The filing explicitly states that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, mitigating risks associated with activist investor involvement from this specific filing.

Future Outlook

This filing is a disclosure of beneficial ownership by an institutional investor and does not contain forward-looking statements or guidance regarding Henry Schein Inc.'s future performance or outlook.

Industry Context

Henry Schein Inc. operates in the healthcare products and services industry, primarily serving dental and medical practitioners. The Vanguard Group's significant stake reflects its broad market investment strategy, often including major players in various sectors.

Comparison to Industry Standards

• As a major institutional investor and index fund manager, The Vanguard Group's significant stake in a publicly traded company like Henry Schein Inc. is consistent with its investment strategy of broad market exposure.
• This type of passive ownership is standard for large asset managers tracking market indices and does not imply a specific investment thesis beyond market representation.

Stakeholder Impact

• Shareholders may view the continued significant ownership by a large institutional investor like Vanguard as a sign of stability and long-term confidence in Henry Schein Inc.

Key Dates

Recommendation

The filing is a routine disclosure of beneficial ownership by a passive institutional investor, The Vanguard Group. It indicates a significant, but non-controlling, stake in Henry Schein Inc. and does not provide new information regarding the company's operational performance or strategic direction that would warrant a change from a 'hold' position.

Keywords

Henry Schein, Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investment, Dental Supply, Medical Supply